Journal of Cell Signaling
Open Access

Dr, Ludwig Institute for Cancer Research Ltd., Science for Life Laboratory, Uppsala University, Uppsala, Sweden

Biography

Carl-henrik Heldin is at Uppsala University in Uppsala, Sweden. Their top areas of expertise are Breast Cancer, Acute Myelomonocytic Leukemia, Necrosis, and Prostate Cancer. Their clinical research consists of co-authoring 133 peer-reviewed articles in the past 15 years.

Publications

• Editorial   
  Posterior Effects of Cell Signaling
  Author(s): Carl-Henrik Heldin*
  
  DOI: 10.35248/2576-1471.20.6.247

  HTML PDF